Drug recall D-0027-2022
Product
Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775 India NDC# 68180-316-06
Reason for recall
Out of specification result observed in a dissolution test at the 9-month long term stability time point.
Lots and codes
lot H002205, exp. date 08/2023
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 1,902 bottles
- Distribution
- Distributed Nationwide in the USA.
- Type
- Voluntary: Firm initiated
- Recall initiated
- October 8, 2021
- Terminated
- March 13, 2023
Related products
- Imipramine Pamoate – drug information
- NDC 68180-317 Imipramine Pamoate · Imipramine Pamoate 150 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-315 Imipramine Pamoate · Imipramine Pamoate 100 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-314 Imipramine Pamoate · Imipramine Pamoate 75 mg/1 · Lupin Pharmaceuticals, Inc.
- NDC 68180-316 Imipramine Pamoate · Imipramine Pamoate 125 mg/1 · Lupin Pharmaceuticals, Inc.